American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 2.
Thomson Scientific, 77 Hatton Garden, London, EC1N 8JS, UK. karen.walker@thomson.com
Karen
K
Walker
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D035843:Biomedical Research / Q000379:methods / Q000639:trends; D002986:Clinical Trials as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D015394:Molecular Structure; D009369:Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000737:chemistry / Q000627:therapeutic use
D000970:Antineoplastic Agents; C111217:vinflunine; D014747:Vinblastine